Continuum Advisory LLC Cuts Holdings in Welltower Inc. $WELL

Continuum Advisory LLC lowered its stake in Welltower Inc. (NYSE:WELL) by 44.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,117 shares of the real estate investment trust’s stock after selling 2,529 shares during the period. Continuum Advisory LLC’s holdings in Welltower were worth $707,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Revolve Wealth Partners LLC grew its position in shares of Welltower by 3.3% during the second quarter. Revolve Wealth Partners LLC now owns 1,392 shares of the real estate investment trust’s stock worth $316,000 after buying an additional 45 shares in the last quarter. Family Wealth Partners LLC raised its holdings in Welltower by 1.3% in the second quarter. Family Wealth Partners LLC now owns 3,678 shares of the real estate investment trust’s stock valued at $835,000 after acquiring an additional 48 shares in the last quarter. Natural Investments LLC raised its holdings in Welltower by 3.0% in the second quarter. Natural Investments LLC now owns 1,673 shares of the real estate investment trust’s stock valued at $379,000 after acquiring an additional 48 shares in the last quarter. Summit Securities Group LLC lifted its stake in Welltower by 42.6% in the second quarter. Summit Securities Group LLC now owns 164 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 49 shares during the last quarter. Finally, Parkside Financial Bank & Trust lifted its stake in Welltower by 2.5% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,977 shares of the real estate investment trust’s stock worth $367,000 after acquiring an additional 49 shares during the last quarter. Hedge funds and other institutional investors own 94.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Cantor Fitzgerald increased their price objective on shares of Welltower from $235.00 to $260.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Evercore reaffirmed an “outperform” rating and set a $260.00 price objective on shares of Welltower in a research report on Thursday, July 30th. Weiss Ratings downgraded shares of Welltower from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Wednesday, June 24th. Citigroup increased their target price on Welltower from $255.00 to $275.00 and gave the company a “buy” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft raised their price target on Welltower from $215.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, July 1st. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $251.06.

Welltower Stock Down 2.1%

WELL stock opened at $236.07 on Friday. The company has a current ratio of 3.16, a quick ratio of 3.16 and a debt-to-equity ratio of 0.37. Welltower Inc. has a twelve month low of $163.75 and a twelve month high of $255.20. The company’s 50 day moving average is $237.37 and its two-hundred day moving average is $218.77. The stock has a market cap of $170.15 billion, a P/E ratio of 108.29, a PEG ratio of 1.15 and a beta of 0.76.

Welltower (NYSE:WELL) last issued its earnings results on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.66 by ($0.05). The company had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.40 billion. Welltower had a net margin of 12.15% and a return on equity of 3.56%. The company’s quarterly revenue was up 39.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.28 EPS. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Research analysts expect that Welltower Inc. will post 6.43 earnings per share for the current fiscal year.

Welltower Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 20th. Shareholders of record on Wednesday, August 12th were paid a $0.85 dividend. This is a boost from Welltower’s previous quarterly dividend of $0.74. This represents a $3.40 annualized dividend and a yield of 1.4%. The ex-dividend date was Wednesday, August 12th. Welltower’s payout ratio is currently 155.96%.

Insider Transactions at Welltower

In other news, Director Andrew Gundlach acquired 5,000 shares of the company’s stock in a transaction on Tuesday, August 25th. The shares were bought at an average price of $239.47 per share, with a total value of $1,197,350.00. Following the completion of the acquisition, the director owned 25,000 shares in the company, valued at $5,986,750. This trade represents a 25.00% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.37% of the stock is owned by corporate insiders.

About Welltower

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.